Pharmaceuticals Market Research Reports & Industry Analysis
Pharmaceuticals Industry Research & Market Reports
-
Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024
... projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs ... Read More
-
Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024
... projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs ... Read More
-
Global Multivitamin and Mineral Supplements Market 2018-2022
... to overcome the deficiency of vitamins and minerals in the regular diet. Technavio’s analysts forecast the Global Multivitamin and Mineral Supplements Market to grow at a CAGR of 4.60% during the period 2018-2022. Covered in ... Read More
-
Global Sjogren’s Syndrome Therapeutics Market 2018-2022
... and moisture-secreting glands in the mouth secrete smaller amounts of saliva. Technavio’s analysts forecast the Global Sjogren’s Syndrome Therapeutics Market to grow at a CAGR of 4.12% during the period 2018-2022. Covered in this report ... Read More
-
Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018-2022
... (fast-growing), complex, and difficult-to-treat form of NHL, which refers to a group of cancers of the lymphatic system. Technavio’s analysts forecast the Global DLBCL Therapeutics Market to grow at a CAGR of 7.64% during the ... Read More
-
Zimbabwe Pharmaceuticals & Healthcare Q4 2018
... multinational drugmakers are deterred by thechallenging macroeconomic environment. Achieving self-sufficiency in the sector will require currency regime reform; however, itremains unclear which new regime they will adopt. This creates uncertain conditions in Zimbabwe's pharmaceutical market ... Read More
-
Panama Pharmaceuticals & Healthcare Q4 2018
... system inefficiencies will continueto weigh on the country’s ability to improve access to healthcare. Sustained pro-growth economic policies and the Panama Canalwill continue to support the country’s position as a logistic and export hub, including ... Read More
-
Azerbaijan Pharmaceuticals & Healthcare Q4 2018
... pharmaceutical market, we remain cautious about its commercial attractiveness to multinationals, at least in theshort term. The over-reliance on out-of-pocket payments has made the market vulnerable to economic fluctuations, especiallygiven its reliance on imported medicines. Read More
-
Namibia Pharmaceuticals & Healthcare Q4 2018
... and efficiency issues within the public healthcare sector. The small middle-and upper-class segments provide pockets of demand for innovative medicines, which will continue to be imported by key regionalplayers and representative offices of established multinationals. Read More
-
Poland Pharmaceuticals & Healthcare Q4 2018
... future of the Fund; however, the outlook for the pharmaceutical market andhealthcare sector remain positive. Continued state healthcare funding growth and consumer-led economic growth will provide aboost to market expenditure, maintaining the country's regional outperformance. Read More
-
Global Gastrointestinal Endoscopy Market: Industry Analysis & Outlook (2018-2022)
... their method of diagnosis and treatment a constantly evolving field. As such endoscopy emerges out as the gold standard for diagnosis of GI cancers. Early diagnosis of GI tumors by endoscopy at the precancerous or ... Read More
-
Global Radiology Information Systems Market 2018-2022
... of patients. Technavio’s analysts forecast the Global Radiology Information Systems Market to grow at a CAGR of 1.33% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth ... Read More
-
Global Peripheral Neuropathy Treatment Market 2018-2022
... is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology. Technavio’s analysts forecast the Global Peripheral Neuropathy Treatment Market to grow at a CAGR of 3.5% ... Read More
-
Honduras Pharmaceuticals & Healthcare Q4 2018
... in Central America. The limited demand forpatented medicines is highlighted by the country’s low per capita spending on medicines. However, a growing burden of chronicdiseases driven by ageing demographics in addition to planned healthcare reforms ... Read More
-
Tunisia Pharmaceuticals & Healthcare Q4 2018
... will challenge foreign investment into the sector.Highlighting the market's longer-term potential, some multinational drugmakers have shown their willingness to do business in thecountry, though the majority choose to operate indirectly to minimise the risks involved. Read More
-
Gabon Pharmaceuticals & Healthcare Q4 2018
... by factors including modest but growingpopulation numbers, high prevalence of infectious diseases and the growing burden of civilisation diseases. However, given thetight funding environment, most of the commercial opportunities remain limited to the generics sector. Read More
-
Venezuela Pharmaceuticals & Healthcare Q4 2018
... crisis in Venevzuela will continue to restrict healthcare spending, limiting public access to medicine andhealthcare services. Medicine shortages will persist with continued hyperinflation, the re-denomination of the Venezuelan bolívarand reduced drugmaker activities in the country. Read More
-
Global Contraceptive Market: Industry Analysis & Outlook (2018-2022)
... been introduced in 20th century only. Today, the market is filled with number of contraceptive options providing desirable results and efficacy. The global contraceptive market is experiencing a robust growth at a lucrative CAGR. Every ... Read More
-
Myanmar Pharmaceuticals & Healthcare Q4 2018
... underdeveloped state of the public health sector will shape commercialopportunities for private healthcare providers. Despite this, the upcoming rollout of universal healthcare coverage will improve long-term opportunities for investment in Myanmar’s pharmaceutical and healthcare sectors. Read More
-
Austria Pharmaceuticals & Healthcare Q4 2018
... sizecompared to its EU partners. However, like its eurozone neighbours, we believe Austria's pharmaceutical spending will be subduedover the medium term, as states scramble to contain rising pharmaceutical expenditure in line with increasing healthcare demands. Read More
-
Pakistan Pharmaceuticals & Healthcare Q4 2018
... especially in light of the uncertainpolicy directions. In addition, the Pakistan-Tehreek-e-Insaf (PTI) political party is expected to upscale health coverage, increase thenumber of emergency units and generally implement programmes to improve health outcomes. Furthermore, the ... Read More
-
Slovakia Pharmaceuticals & Healthcare Q4 2018
... be driven bygovernment plans to improving access to health services with hospital reforms and diseases prevention programs. However, thegovernment’s implementation of cost-containment measures and the growing use of generic medicines will limit opportunities forinnovative drugmakers. Read More
-
2018 Germany HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
... confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs- Blood Banks The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, Biotest, bioMerieux, Bio-Rad, ... Read More
-
2018 Italy HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
... confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs- Blood Banks The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, DiaSorin, ... Read More
-
2018 Spain HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
... confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs- Blood Banks The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, Biokit, bioMerieux, Bio-Rad, ... Read More
